Complement C1QC as a potential prognostic marker and therapeutic target in colon carcinoma based on single-cell RNA sequencing and immunohistochemical analysis. (2022). Biomolecules and Biomedicine, 22(6), 912-922. https://doi.org/10.17305/bjbms.2022.7309